Cadent Therapeutics

@CadentTx

We're on a mission to develop treatments to restore brain rhythms & improve outcomes for those living with movement, mood, & cognitive disorders.

Vrijeme pridruživanja: listopad 2017.

Tweetovi

Blokirali ste korisnika/cu @CadentTx

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CadentTx

  1. Prikvačeni tweet
    23. sij

    Cadent Therapeutics Announces FDA acceptance of IND Application for CAD-1883 for Spinocerebellar Ataxia (SCA)

    Poništi
  2. prije 3 sata

    We’re excited to be at the Northeastern College of Science mixer tonight. Stop by table 1 for some icebreakers!

    Poništi
  3. proslijedio/la je Tweet
    27. sij

    has announced that is has received an investigational new drug approval (IND) from the FDA for -1883, which is being assessed for the treatment of .

    Poništi
  4. 22. sij

    Cadent CEO Jodie Morrison is mentioned in Rob Wright’s article “The Leadership Meeting- Where Leaders Go to Learn” as he recalls the Leadership Meeting held prior to JPM

    Poništi
  5. 13. sij

    Cadent CEO, Jodie Morrison and CMO, Dr. Christopher Kenney were honored to be part of the opening bell ceremony this morning in San Francisco

    Poništi
  6. 2. sij

    Happy New Year and welcome back! The Cadent clinical team is expanding. Visit our careers page and check out our latest opportunities to join the !

    Poništi
  7. 23. pro 2019.

    Wishing everyone peaceful and happy holidays!

    Poništi
  8. 10. pro 2019.

    Our CSO, Tim Piser is presenting tonight at the ACNP Annual Meeting on CAD-9303 our novel candidate therapeutic for cognitive impairment and negative symptoms in schizophrenia. Stop by poster 226 from 5:30-7:30PM

    Poništi
  9. 10. pro 2019.

    Cadent Therapeutics Announces Poster Presentation at the 2019 Annual Meeting of the American College of Neuropsychopharmacology (ACNP)

    Poništi
  10. 10. pro 2019.

    Our CEO, Jodie Morrison speaking on “Diversity Initiatives That Work” as part of the Diversity & Inclusion Forum: Perspectives & Possibilities for the Life Science Industry. Special thanks to for hosting!

    Poništi
  11. 9. pro 2019.

    Come join the Rhythm Makers! Check out the latest opening at Cadent Therapeutics for Associate Director, Clinical Operations with the opportunity to lead clinical operations activities across one or more of our clinical development programs

    Poništi
  12. proslijedio/la je Tweet
    5. pro 2019.

    Listen to the "Tremor" podcast featuring Dr. Rodger Elble. He talks about studies on new drugs for and the latest research. Thank you to for this podcast series!

    Poništi
  13. 5. pro 2019.

    We welcomed another new Rhythm Maker last week! Check out our careers page for more opportunities to join the team:

    Poništi
  14. 2. pro 2019.

    Jodie Morrison, the Company’s Chief Executive Officer, will present at the Piper Jaffray 31st Annual Healthcare Conference

    Poništi
  15. proslijedio/la je Tweet

    Cadent Therapeutics to Present at Upcoming Investor Conferences

    Poništi
  16. 14. stu 2019.

    Cadent Therapeutics to Present at Upcoming Investor Conferences

    Poništi
  17. 8. stu 2019.

    Cadent Therapeutics is hiring an Associate Director of Clinical Operations. Check out our careers page and apply today!

    Poništi
  18. proslijedio/la je Tweet
    6. stu 2019.

    What an inspiring event to attend! Thank you for providing an opportunity for all involved in advocacy to connect.

    Poništi
  19. 31. lis 2019.

    Happy Halloween from the Cadent Team!

    Poništi
  20. 30. lis 2019.

    We welcomed another Rhythm Maker this month! Interested in joining the team? Check out our careers page:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·